Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.054 | 0.7 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |